Pharmaceutical - AstraZeneca

Filter

Current filters:

AstraZeneca

Popular Filters

226 to 250 of 317 results

First success of selumetinib, a targeted therapy in most common NSCLC

29-11-2012

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists…

Array BioPharmaAstraZenecaOncologyPharmaceuticalResearchselumetinib

Big Pharma doing more for access to medicine in developing countries than two years ago

28-11-2012

The latest Access to Medicine Index, which ranks the top 20 pharmaceutical companies on their efforts…

AstraZenecaBayerGlaxoSmithKlineGlobalHealthcareJohnson & JohnsonMerck KGaAPharmaceuticalPricingResearch

Asthma preventive drugs market led by GlaxoSmithKline's Advair

26-11-2012

The asthma preventive drugs market has been forecast to increase at a compound annual growth rate (CAGR)…

AdvairAstraZenecaGlaxoSmithKlineMarkets & MarketingMerck & CoPharmaceuticalRespiratory and PulmonarySingulairSymbicort

AstraZeneca and Bristol-Myers get first approval for diabetes drug Forxiga

15-11-2012

There was good news for AstraZeneca (LSE: AZN) and Bristol-Myers Squibb (NYSE: BMY), with the European…

AstraZenecaBristol-Myers SquibbdapagliflozinDiabetesEuropeForxigaPharmaceuticalRegulation

Germany invalidates Seroquel patent; Merck drops combo diabetes drug development

14-11-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) said last evening that the Federal Patent Court in Germany…

AstraZenecaatorvastatinCardio-vascularDiabetesJanuviaMerck & CoMK-0431ENeurologicalPatentsPharmaceuticalResearchSeroquel XR

Russian prostate cancer market expected to grow 6% annually from 2011 to 2016

01-11-2012

The total number of diagnosed incident cases of prostate cancer in Russia will increase at five percent…

AstraZenecaBuserelinEuropeMarkets & MarketingOncologyPharm-SintezPharmaceuticalZoladex

£7 million funding for MRC-AstraZeneca compound collaboration

30-10-2012

The UK's Medical Research Council (MRC) will today (October 31) announce £7 million ($11.3 billion)…

AstraZenecaFinancialPharmaceuticalResearch

New CEO Pascal Soriot to get over $6 million for moving to AstraZeneca

30-10-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has made a regulatory disclosure following the grant…

AstraZenecaFinancialManagementPharmaceutical

News briefs: Bayer's Stivarga and AstraZeneca's Faslodex

30-10-2012

German drug major Bayer (BAYN: DE) and US partner Onyx Pharmaceuticals (Nasdaq: ONXX) said yesterday…

AstraZenecaBayerFaslodexNorth AmericaOncologyOnyx PharmaceuticalsPharmaceuticalRegulationResearchStivarga

AstraZeneca 3rd-qtr 2012 takes heavy hit from generics

25-10-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed this morning that group sales for the third…

AstraZenecaFinancialPharmaceutical

AstraZeneca gains rights to sell Ironwood's IBS drug in China

24-10-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has entered into an agreement with the USA's Ironwood…

Asia-PacificAstraZenecaGastro-intestinalsIronwood PharmaceuticalsLicensinglinaclotideMarkets & MarketingNexiumNorth AmericaPharmaceutical

AstraZeneca's Brilinta rolls out in India

18-10-2012

The Indian subsidiary of Anglo-Swedish drug major AstraZeneca (LSE: AZN) yesterday launched its patented…

Asia-PacificAstraZenecaBrilintaCardio-vascularMarkets & MarketingPharmaceutical

AstraZeneca partners with China's Pharmaron to accelerate drug discovery

15-10-2012

Pharmaron, a China-based R&D service provider for the pharmaceutical and biotech industries with operations…

AstraZenecaLicensingPharmaceuticalPharmaronResearch

News briefs: AstraZeneca suspends share repurchasing; New CMO for Sanofi; Research facility for Octapharma

02-10-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) saw its shares dip 1.8% to £29.02 in early afternoon…

AstraZenecaFinancialManagementOctapharmaPharmaceuticalResearchSanofi

Pharmaceutical majors unite in Japan to combat H. pylori

18-09-2012

On August 31, nine pharmaceutical companies operating in Japan (Kyowa Hakko Kirin, Takeda Pharmaceutical,…

Antibiotics and Infectious diseasesAsia-PacificAstraZenecaGastro-intestinalsPharmaceuticalRegulationTakeda Pharmaceuticals

Resubmission of aripiprazole NDA accepted; AstraZeneca bond issue

12-09-2012

Danish CNS-focused drugmaker Lundbeck (LUND: DC) and Japanese partner Otsuka Pharmaceutical (TYO: 4668)…

aripiprazole depotAstraZenecaFinancialLundbeckNeurologicalNorth AmericaOtsukaPharmaceuticalRegulation

STEMI guidelines now recommend AstraZeneca's ticagrelor as first-line treatment option

30-08-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) said yesterday that ticagrelor, its oral antiplatelet…

AstraZenecaBrilintaBriliqueCardio-vascularEffientEli LillyPharmaceuticalRegulation

226 to 250 of 317 results

Parexel

Parexel

Back to top